Table 3 Logrank and Cox cause-specific hazard ratios (csHR), subdistribution hazard ratios (subHR) and associated 95% confidence intervals for evaluating the treatment effect
From: Analysis and design of randomised clinical trials involving competing risks endpoints
| Â | Unadjusted csHR | Unadjusted subHR | |
|---|---|---|---|
Competing event | Logrank | Cox | Subdistribution |
M: Distant metastasis | 0.43 (0.25 - 0.72) | 0.43 (0.24 - 0.75) | 0.43 (0.25 - 0.76) |
R: Loco-regional recurrence | 0.84 (0.34 - 2.07) | 0.84 (0.34 - 2.08) | 0.91 (0.37 - 2.24) |